EN
抗体药类似物
Research Grade Odronextamab
All
TD-HY257156_1.jpg
  • CatalogTD-HY257156
  • ClonalitymAb
  • Application Research Grade Biosimilar
  • SynonymsBispecific, REGN-1979, CAS: 1801338-64-6
  • 规格
    1mg
  • 价格
    ¥询价
定制服务咨询

Research Grade Odronextamab


Catalog No. TD-HY257156
Species reactivity Human
Applications Research Grade Biosimilar
Host species Human
Isotype IgG4-kappa
Expression system Mammalian Cells
Species Human
Clonality Monoclonal
Target B-lymphocyte surface antigen B1, Membrane-spanning 4-domains subfamily A member 1, MS4A1, Leukocyte surface antigen Leu-16, B-lymphocyte antigen CD20, Bp35, CD20, T3E, T-cell surface antigen T3/Leu-4 epsilon chain, CD3e, CD3E, T-cell surface glycoprotein CD3 epsilon chain
Endotoxin level Please contact with the lab for this information.
Purity >95% as determined by SDS-PAGE.
Purification Protein A/G purified from cell culture supernatant.
Accession P11836 & P07766
Form Liquid
Storage buffer 0.01M PBS, pH 7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Alternate Names Bispecific, REGN-1979, CAS: 1801338-64-6
Background Odronextamab is a stable humanized IgG4 CD20 × CD3 bispecific antibody that binds to CD3 on T cells and CD20 on B cells, triggering anti-tumor activity. Odronextamab is expected to be used in oncology research.
Note For research use only. Not suitable for clinical or therapeutic use.

 

TD-HY257156_1.jpg
SDS-PAGE
 
SDS-PAGE for Research Grade Odronextamab.